Pediculosis is induced by infestation of blood feeding Phthiraptera as well as an ectoparasitic insect Louse.
This report contains market size and forecasts of Pediculosis Treatment in Global, including the following market information:
Global Pediculosis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Pediculosis Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
by Louse Type Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pediculosis Treatment include American Vanguard Corporation(TyraTech, Inc.), Tec Laboratories Inc., Arbor Pharmaceuticals LLC, Logic Product Group, The Harvard Drug Group(Major Pharmaceuticals), ParaPRO, LLC, Prestige Consumer Healthcare, Inc., Bayer AG and STADA Arzneimittel AG(Thornton & Ross) and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pediculosis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pediculosis Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Pediculosis Treatment Market Segment Percentages, by Type, 2021 (%)
by Louse Type
Pediculosis Capitis
Pediculosis Pubis
Pediculosis Corporis
by Treatment
Dimeticone Lotion
Isopropyl Alcohol
Suffocation-Based Pediculicide
Petrolatum
Mercuric Oxide Ointment
Others
Global Pediculosis Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Pediculosis Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Home Care
Others
Global Pediculosis Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Pediculosis Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pediculosis Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Pediculosis Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
American Vanguard Corporation(TyraTech, Inc.)
Tec Laboratories Inc.
Arbor Pharmaceuticals LLC
Logic Product Group
The Harvard Drug Group(Major Pharmaceuticals)
ParaPRO, LLC
Prestige Consumer Healthcare, Inc.
Bayer AG
STADA Arzneimittel AG(Thornton & Ross)
Lavipharm